Innovative Medicines Canada statement on the House of Commons Health Committee Study of Pharmacare

OTTAWA, April 13, 2016 /CNW/ – As the House of Commons Standing Committee on Health begins its study on the feasibility of a national pharmacare program, Innovative Medicines Canada issued the following statement:

“Innovative Medicines Canada is proud to be an integral part of our…